Vertex Pharmaceuticals (VRTX) Exchanges $103.3M In Convertible Notes Into Common Stock
Up)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) said holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $103.3 million in aggregate principal amount of those notes for approximately 4.8 million shares of the Company's common stock, which is approximately 287,000 shares more than the number of shares into which the notes were convertible under their original terms.
You May Also Be Interested In
- Vertex Appoints David Altshuler, M.D., Ph.D., to its Board of Directors
- Stereotaxis (STXS) To Offer 28.2M Shres
- Rentech (RTK) Files 614K Common Shelf for Shareholder
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
